At this week's San Antonio Breast Cancer Symposium (SABCS), breast tumor localization technology provider Cianna Medical is highlighting preliminary data documenting the safe use of its SAVI Scout to localize axillary lymph nodes before starting chemotherapy treatment.
In the poster presentation, researchers from Envision Physician Services reported that they were able to locate all of the target lymph nodes in 24 patients with the SAVI Scout device, prior to neoadjuvant chemotherapy treatment (NAT).
"Image-guided wire-free radar localization may replace the more difficult and less reliable wire localization currently done after NAT response," presenter and lead author Dr. Mary Hayes said.
"This may be a more precise method of identifying the biopsy-proven positive lymph node following NAT and assuring its removal at the time of surgery," co-author Dr. Erica Bloomquist added.
Cianna Medical is a subsidiary of disposable products developer Merit Medical Systems.
